Anthem Biosciences Ltd.

₹774.3

4.5 (0.6%)

ANTHEM Share Price

Pharmaceuticals & Biotechnology

As on April 28, 2026

Sector

IndustryPharmaceuticals & Biotechnology

Basic IndustryBiotechnology

Market Cap₹ 43,533 Cr

P/E Ratio95.93

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	756.7	Bullish
10-DMA	741.97	Bullish
20-DMA	714.99	Bullish
50-DMA	688.16	Bullish
100-DMA	664.73	Bullish
200-DMA	---

Historical Performance

1 Year

N/A

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	18,446	14,194	10,569	12,313	11,032
Total Expenditure	11,735	9,143	6,341	6,642	6,955
Other Income	857	637	850	490	372
Operating Profit	7,568	5,688	5,079	6,161	4,449
Interest	105	97	87	122	170
Depreciation	894	818	637	578	624
Profit Before Tax	6,569	4,773	4,973	5,461	3,656
Consolidated Net Profit	4,513	3,673	3,852	4,055	2,713
Adjusted EPS	8	7	7	7	5

Compounded Sales Growth

10 Years:49.4

5 Years:23.9

3 Years:8.4

TTM:5.4

Compounded Profit Growth

10 Years:63.2

5 Years:37.2

3 Years:2.2

TTM:4.2

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:N/A

Return on Equity

10 Years:0.3

5 Years:4.9

3 Years:6.8

last year:8.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,118	1,118	1,141	88	85
Total Reserves	22,637	18,128	16,266	13,462	6,930
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	535	934	850	217	335
Other Current Liabilities	1,273	1,073	536	1,094	1,021
Short Term Borrowings	619	1,209	289	296	803
Total Liabilities	29,486	24,767	21,045	17,259	10,910
Capital Work in Progress	2,969	3,447	1,641	1,538	187
Long Term Loans & Advances	313	346	467	223	238
Currents Investments	4,161	4,591	4,929	2,691	2,091
Short Term Loans and Advances	3,620	2,530	1,958	2,040	1,431
Total Current Assets	18,957	16,016	14,382	12,163	6,868
Total Assets	29,486	24,767	21,045	17,259	10,910
Adjusted Book Value	42	34	31	24	13

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 95.93, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered price CAGR data is unavailable.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹7568 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹18446 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1060176.6

No. of Shares: 1369 (Approx)

Performance:6%

P/L: ₹60176.6

NIFTY Performance: -1.4%

1 day Top Gainers